Los Angeles California | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
| Stages | Pre-Seed, Seed, Early Stage, Series A, Series B, Series C, Pre-IPO |
| Investing | United States • Canada • Germany • Mexico • Netherlands • Israel |
| Investment Range | $100,000 - $2,000,000 |
| Investment Sweet Spot | $250,000 |
About The Fund
PsyMed Ventures is a venture capital fund headquartered in Los Angeles, California, focused on investing in groundbreaking mental health technologies and psychedelic medicine. They fund pre-seed to Series C and Pre-IPO stages with investments ranging from $100,000 to $2,000,000, aiming at a sweet spot of $250,000 per investment. The firm primarily supports startups in the BioTech, HealthTech & Fitness, Medical Devices & Hospital Services, DeepTech, Healthcare & Wellness, Consumer, Pharmaceutical & Medicine, and Woman Focused industries. PsyMed Ventures is intrigued by psychedelic medicine, digital therapeutics, neurotech, and precision psychiatry. They are committed to supporting founders who are pioneering advances in brain and mental health by leveraging innovative neuroscience and frontier technologies. PsyMed Ventures positions itself at the intersection of responsible healing and profitability, believing in the transformative power of their portfolio companies to address the global mental and brain illness epidemic. Their investment focus covers neurotech and brain-computer interfaces (BCI), digital health solutions, precision psychiatry methodologies, digital therapeutics with proven clinical benefits, holistic and metabolic approaches to psychiatry, and the exploration of psychedelic medicine and new compounds for treatment of various conditions. PsyMed Ventures has made notable investments in neurosciences and biotech companies developing advanced algorithms, machine learning for early detection and personalized treatment, and non-hallucinogenic versions of psychedelic compounds. Their portfolio includes companies working on microbiome therapeutics, AI-assisted therapy tools, and VR/AR platforms for mental health and wellness. PsyMed further demonstrates their commitment to the psychedelic community by donating a portion of their profits to relevant non-profits and indigenous communities. The team comprises experienced investors, entrepreneurs, and community builders each with their own unique contributions to the mental health and biotech ecosystems.
What they say:
We invest in psychedelic medicine and mental health tech.
PsyMed Ventures's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
